Dapagliflozin Patient Satisfaction Survey

Trial Identifier:	D1690R00026
Sponsor:	AstraZeneca
Collaborator:	Optum
NCTID::	NCT02805283
Start Date:	June 2016
Primary Completion Date:	October 2018
Study Completion Date:	October 2018
Condition:	Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States of America, MN	Eden Prairie, MN, United States of America

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.